125 related articles for article (PubMed ID: 28839912)
21. Factors influencing pharmacy services in opioid substitution treatment.
Chaar BB; Wang H; Day CA; Hanrahan JR; Winstock AR; Fois R
Drug Alcohol Rev; 2013 Jul; 32(4):426-34. PubMed ID: 23442133
[TBL] [Abstract][Full Text] [Related]
22. Developing and testing evidence-based weight management in Australian pharmacies: A Healthier Life Program.
Um IS; Krass I; Armour C; Gill T; Chaar BB
Int J Clin Pharm; 2015 Oct; 37(5):822-33. PubMed ID: 25920908
[TBL] [Abstract][Full Text] [Related]
23. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand.
Hansen RA; Roth MT; Brouwer ES; Herndon S; Christensen DB
J Am Pharm Assoc (2003); 2006; 46(6):700-6. PubMed ID: 17176685
[TBL] [Abstract][Full Text] [Related]
24. A national survey exploring oral healthcare service provision across Australian community pharmacies.
Freeman CR; Abdullah N; Ford PJ; Taing MW
BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
[TBL] [Abstract][Full Text] [Related]
25. Exploring the prevalence of and factors associated with advice on prescription medicines: A survey of community pharmacies in an English city.
Rivers PH; Waterfield J; Grootveld M; Raynor DK
Health Soc Care Community; 2017 Nov; 25(6):1774-1786. PubMed ID: 28486784
[TBL] [Abstract][Full Text] [Related]
26. A pharmacy carer support service: obtaining new insight into carers in the community.
McMillan SS; King MA; Stapleton H; Sav A; Kelly F; Wheeler AJ
Int J Pharm Pract; 2019 Feb; 27(1):34-44. PubMed ID: 29732644
[TBL] [Abstract][Full Text] [Related]
27. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training.
Sheridan J; Strang J; Taylor C; Barber N
Addiction; 1997 Dec; 92(12):1737-48. PubMed ID: 9581006
[TBL] [Abstract][Full Text] [Related]
28. Testing evidence routine practice: Using an implementation framework to embed a clinically proven asthma service in Australian community pharmacy.
Fuller JM; Saini B; Bosnic-Anticevich S; Garcia Cardenas V; Benrimoj SI; Armour C
Res Social Adm Pharm; 2017; 13(5):989-996. PubMed ID: 28583300
[TBL] [Abstract][Full Text] [Related]
29. Cost analysis of a novel HIV testing strategy in community pharmacies and retail clinics.
Lecher SL; Shrestha RK; Botts LW; Alvarez J; Moore JH; Thomas V; Weidle PJ
J Am Pharm Assoc (2003); 2015; 55(5):488-92. PubMed ID: 26359959
[TBL] [Abstract][Full Text] [Related]
30. Adoption of a biometric screening service in community pharmacies: a qualitative study.
Teeter BS; Braxton-Lloyd K; Armenakis AA; Fox BI; Westrick SC
J Am Pharm Assoc (2003); 2014; 54(3):258-66. PubMed ID: 24816352
[TBL] [Abstract][Full Text] [Related]
31. Patient care services in rural Minnesota community pharmacies.
Haag JD; Stratton TP
J Am Pharm Assoc (2003); 2010; 50(4):508-16. PubMed ID: 20621869
[TBL] [Abstract][Full Text] [Related]
32. Early recognition of coeliac disease through community pharmacies: a proof of concept study.
Urwin H; Wright D; Twigg M; McGough N
Int J Clin Pharm; 2016 Oct; 38(5):1294-300. PubMed ID: 27503280
[TBL] [Abstract][Full Text] [Related]
33. Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort study.
Øvrehus A; Nielsen S; Hansen JF; Holm DK; Christensen P
Addiction; 2019 Mar; 114(3):494-503. PubMed ID: 30347471
[TBL] [Abstract][Full Text] [Related]
34. Exploring opportunities for providing pharmacists with feedback on their practice and performance around the electronic Minor Ailments Service in Scotland.
Paudyal V; Hansford D; Cunningham S; Stewart D
Int J Pharm Pract; 2014 Oct; 22(5):319-26. PubMed ID: 24423237
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.
Houle SK; Charrois TL; Faruquee CF; Tsuyuki RT; Rosenthal MM
Res Social Adm Pharm; 2017; 13(2):339-348. PubMed ID: 27017157
[TBL] [Abstract][Full Text] [Related]
36. 'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings.
Rance J; Treloar C;
Addiction; 2014 Mar; 109(3):452-9. PubMed ID: 24678545
[TBL] [Abstract][Full Text] [Related]
37. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
Hanes CA; Wong KK; Saini B
Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
[TBL] [Abstract][Full Text] [Related]
38. Influences on the frequency and type of community pharmacy services.
Doucette WR; Rippe JJ; Gaither CA; Kreling DH; Mott DA; Schommer JC
J Am Pharm Assoc (2003); 2017; 57(1):72-76.e1. PubMed ID: 27777075
[TBL] [Abstract][Full Text] [Related]
39. Senior nurses' perspectives on the transfer of opioid substitution treatment clients from clinics to community pharmacy.
Bui J; Day C; Hanrahan J; Winstock A; Chaar B
Drug Alcohol Rev; 2015 Sep; 34(5):495-498. PubMed ID: 25302986
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
